• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症疫苗:研究与应用

Cancer Vaccines: Research and Applications.

作者信息

Apostolopoulos Vasso

机构信息

Institute for Health and Sport, Victoria University, Melbourne 3030, Australia.

出版信息

Cancers (Basel). 2019 Jul 24;11(8):1041. doi: 10.3390/cancers11081041.

DOI:10.3390/cancers11081041
PMID:31344788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6721783/
Abstract

Designing cancer vaccines has been at the forefront of cancer research for over two-and-a-half decades. In particular, delivery methods used to stimulate effective and long-lasting immune responses have been the major focus. This special issue presents new tumor associated antigens, delivery methods, combination immune therapies, methods of measuring immunity induced following cancer vaccinations, and mechanisms in understanding tumor microenvironments and immunosuppression-all beneficial for the design of improved cancer vaccines.

摘要

二十多年来,癌症疫苗的设计一直处于癌症研究的前沿。特别是,用于激发有效且持久免疫反应的递送方法一直是主要焦点。本期特刊介绍了新的肿瘤相关抗原、递送方法、联合免疫疗法、测量癌症疫苗接种后诱导的免疫的方法,以及理解肿瘤微环境和免疫抑制的机制——所有这些都有利于设计改进的癌症疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d83/6721783/f39922c506d9/cancers-11-01041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d83/6721783/f39922c506d9/cancers-11-01041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d83/6721783/f39922c506d9/cancers-11-01041-g001.jpg

相似文献

1
Cancer Vaccines: Research and Applications.癌症疫苗:研究与应用
Cancers (Basel). 2019 Jul 24;11(8):1041. doi: 10.3390/cancers11081041.
2
Designing effective vaccines for colorectal cancer.设计有效的结直肠癌疫苗。
Immunotherapy. 2014;6(8):913-26. doi: 10.2217/imt.14.61.
3
Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.采用基于纳米颗粒的癌症疫苗接种与免疫检查点阻断联合治疗手术后肿瘤复发。
J Control Release. 2018 Sep 10;285:56-66. doi: 10.1016/j.jconrel.2018.07.011. Epub 2018 Jul 6.
4
Therapeutic gene modified cell based cancer vaccines.治疗性基因修饰的细胞基癌症疫苗。
Gene. 2013 Aug 10;525(2):200-7. doi: 10.1016/j.gene.2013.03.056. Epub 2013 Apr 6.
5
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.基于 NY-ESO-1 的癌症免疫治疗:当前观点。
Front Immunol. 2018 May 1;9:947. doi: 10.3389/fimmu.2018.00947. eCollection 2018.
6
In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.原位疫苗接种:在癌症免疫治疗树上收获低垂的果实。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jan;11(1):e1524. doi: 10.1002/wnan.1524. Epub 2018 Apr 18.
7
Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy.可冻干的多功能 Toll 样受体 7/8 激动剂负载的纳米乳液,用于重塑肿瘤微环境和增强癌症免疫治疗。
ACS Nano. 2019 Nov 26;13(11):12671-12686. doi: 10.1021/acsnano.9b04207. Epub 2019 Oct 11.
8
Roles of regulatory T cells in cancer immunity.调节性T细胞在癌症免疫中的作用。
Int Immunol. 2016 Aug;28(8):401-9. doi: 10.1093/intimm/dxw025. Epub 2016 May 9.
9
Current challenges for cancer vaccine adjuvant development.癌症疫苗佐剂开发的当前挑战。
Expert Rev Vaccines. 2018 Mar;17(3):207-215. doi: 10.1080/14760584.2018.1434000. Epub 2018 Feb 8.
10
Progress in Vaccine Therapies for Breast Cancer.疫苗疗法在乳腺癌治疗中的进展。
Adv Exp Med Biol. 2017;1026:315-330. doi: 10.1007/978-981-10-6020-5_15.

引用本文的文献

1
Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives.癌症对免疫疗法的抗性:综合见解与未来展望
Pharmaceutics. 2023 Apr 4;15(4):1143. doi: 10.3390/pharmaceutics15041143.
2
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy.靶向血红素和线粒体呼吸在使肿瘤微环境正常化及增强免疫治疗方面的前景。
Front Oncol. 2023 Jan 4;12:1072739. doi: 10.3389/fonc.2022.1072739. eCollection 2022.
3
Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer.

本文引用的文献

1
The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer.乳腺癌中肿瘤微环境与免疫检查点之间的复杂相互作用
Cancers (Basel). 2019 Aug 19;11(8):1205. doi: 10.3390/cancers11081205.
2
Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients.IMA950/聚肌胞苷酸-聚左旋赖氨酸-羧甲基纤维素疫苗接种对复发性高级别胶质瘤患者贝伐单抗反应影响的探索性研究
Cancers (Basel). 2019 Apr 2;11(4):464. doi: 10.3390/cancers11040464.
3
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.
癌症免疫疗法:慢性结肠炎与结直肠癌之间的检查点
Cancers (Basel). 2022 Dec 12;14(24):6131. doi: 10.3390/cancers14246131.
4
Immunization of Mice with Gold Nanoparticles Conjugated to Thermostable Cancer Antigens Prevents the Development of Xenografted Tumors.用热稳定肿瘤抗原偶联的金纳米粒子免疫小鼠可预防异种移植肿瘤的发展。
Int J Mol Sci. 2022 Nov 18;23(22):14313. doi: 10.3390/ijms232214313.
5
Self-Amplifying RNA Approach for Protein Replacement Therapy.自我扩增 RNA 方法用于蛋白质替代疗法。
Int J Mol Sci. 2022 Oct 25;23(21):12884. doi: 10.3390/ijms232112884.
6
Checkpoint Markers and Tumor Microenvironment: What Do We Know?检查点标志物与肿瘤微环境:我们了解什么?
Cancers (Basel). 2022 Aug 4;14(15):3788. doi: 10.3390/cancers14153788.
7
Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma.肿瘤特异性工程疫苗在黑素瘤鼠模型中的抗肿瘤作用。
Mar Drugs. 2022 Jun 14;20(6):392. doi: 10.3390/md20060392.
8
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics.利用癌症疫苗激发免疫系统:从预防到治疗
Vaccines (Basel). 2022 May 21;10(5):816. doi: 10.3390/vaccines10050816.
9
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.KRAS 和 MET 基因在非小细胞肺癌中的作用:“驱动基因”家族的新成员。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666211066064. doi: 10.1177/17534666211066064.
10
Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review.提高软组织肉瘤免疫治疗疗效:一种基于生物标志物和组织类型的综述。
Front Immunol. 2021 Dec 3;12:775761. doi: 10.3389/fimmu.2021.775761. eCollection 2021.
共同靶向HER2/Neu和IGF1R的癌症疫苗
Cancers (Basel). 2019 Apr 11;11(4):517. doi: 10.3390/cancers11040517.
4
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations.鉴定源自驱动基因突变的新型HLA II类限制性新抗原
Cancers (Basel). 2019 Feb 24;11(2):266. doi: 10.3390/cancers11020266.
5
Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and Humans.黑色素瘤抗原靶向小鼠和人类CD169⁺抗原呈递细胞后CD8⁺T细胞反应的激活。
Cancers (Basel). 2019 Feb 5;11(2):183. doi: 10.3390/cancers11020183.
6
Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy.使用小干扰RNA释放免疫系统刹车可增强癌症免疫疗法。
Cancers (Basel). 2019 Feb 3;11(2):176. doi: 10.3390/cancers11020176.
7
Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes.用于人乳头瘤病毒相关肿瘤的抗癌疫苗:聚焦基于使用内源性工程化外泌体的新型肿瘤抗原递送方法的治疗性人乳头瘤病毒疫苗。
Cancers (Basel). 2019 Jan 24;11(2):138. doi: 10.3390/cancers11020138.
8
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.高级别胶质瘤宠物犬术后联合CD200免疫检查点抑制剂与肿瘤裂解物疫苗接种的治疗
Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137.
9
Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells.癌症免疫疗法:沉默树突状细胞的细胞内负性免疫调节因子
Cancers (Basel). 2019 Jan 17;11(1):108. doi: 10.3390/cancers11010108.
10
A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model.一种编码与HPV-16 E7抗原融合的SA-4-1BBL的DNA疫苗在宫颈癌小鼠模型中具有预防和治疗效果。
Cancers (Basel). 2019 Jan 15;11(1):96. doi: 10.3390/cancers11010096.